We came across some interesting information dealing with the Medical Affairs function at pharmaceutical and biotechnology companies.
Medical Affairs groups were originally established by pharmaceutical and biotechnology companies to facilitate peer-to-peer interactions between prescribing physicians and company representatives. The Medical Affairs Practice group at Campbell Alliance, a management consulting company focused on the pharmaceutical and biotechnology industry, has a wealth of information about this subject available on their website.
The attached file is an article authored by Tim Dietlin and Keith Morris of Medical Affairs Practice titled “Optimizing the Impact of the Medical Affairs Function.” The article addresses the changes in Medical Affairs, including the separation from marketing, that has occcurred throughout the industry as a result of changing regulations and scientific demand.
medical_affairs_functionoptimizing.pdf
The article begins “To assess the evolving role of Medical Affairs and evaluate current organizational structures, responsibilities, and communication with Marketing, Campbell Alliance conducted primary research to learn how organizations have reacted to their changing environments. Surveys of 13 Medical Affairs directors and vice presidents and 19 Marketing directors across a range of company sizes provided a fascinating look into how the role of Medical Affairs has progressed, and also highlighted the greatest needs for improvement.”
For more information, download the attached file or visit the Medical Affairs Practice website.
